Oncology In-Office Dispensing: Financing a Practice Pharmacy
Oncology in-office dispensing allows a cancer practice to provide oral anticancer therapies and supportive medications directly to patients, rather than sending prescriptions to an outside pharmacy. Often called medically integrated dispensing, it keeps patients connected to their care team and gives the practice more visibility into adherence, side effects and refills.
As more cancer treatments are taken by mouth, many independent practices are considering whether to add a dispensing operation. Doing so requires space, licensed staff, technology and inventory, and each of those has a cost. This guide covers the planning and financing considerations. Pharmacy licensing, dispensing and payer rules vary by state and payer, and nothing here is legal, tax, billing, clinical or compliance advice.
Why Practices Consider Dispensing
Practices that add dispensing often cite several goals:
- Keeping patients within the practice for oral therapy management
- Coordinating oral and infused treatment plans more closely
- Reducing delays patients may face obtaining medications elsewhere
- Adding a service line that may contribute to practice revenue
Whether dispensing is financially viable depends on patient volume, payer access, the drugs involved and how the operation is managed. Results vary, and projections should be reviewed carefully.
Licensing, Payer Access and Compliance
Before investing, practices need to understand the regulatory and payer landscape. Depending on the state, the practice may need a pharmacy license or may dispense under physician dispensing rules. Some payers and pharmacy benefit arrangements limit which pharmacies may fill certain specialty medications, which can affect how many prescriptions the practice can actually dispense.
These issues should be reviewed with healthcare counsel and qualified pharmacy and compliance professionals. Payer participation and network access should not be assumed and may take time to secure.
Planning Oncology In-Office Dispensing Space
A dispensing operation generally needs:
- Secure storage: locked shelving and controlled access for high-value medications
- Climate control: refrigeration and temperature monitoring where required
- Workspace: counting, labeling and verification areas
- Patient counseling area: a private space for education and follow-up
- Shipping capability: if the practice mails medications to patients
Some practices fit dispensing into existing space; others build out a dedicated room or suite. If you are also expanding infusion capacity, our article on oncology infusion suite expansion covers that side of the build-out.
Staffing and Technology
Dispensing typically requires pharmacists and pharmacy technicians, along with staff to handle benefits investigations, prior authorizations and financial assistance for patients. These roles are specialized, and recruiting them may take time.
Technology may include dispensing software, inventory management, adherence tracking and integration with the practice’s health record. Practices should budget for implementation, training and ongoing support.
Inventory and Cash Flow
Oral oncology drugs can be expensive, and the practice may need to purchase them before being paid. Combined with existing buy-and-bill purchasing for infused drugs, dispensing can increase the total cash tied up in inventory and receivables.
Our guide to oncology buy-and-bill cash flow explains how practices manage drug purchasing gaps. Close inventory control can help limit waste and avoid carrying more stock than needed.
Financing a Practice Pharmacy
A dispensing launch may combine several types of financing:
- Expansion or term loans: for build-out, fixtures and technology
- Working capital lines: for initial inventory and ongoing purchasing
- Practice cash: often used alongside financing
Conventional practice loans may fit established practices adding a service line. For inventory and day-to-day needs, our oncology working capital lines of credit and broader working capital solutions may help.
Lenders generally review the practice’s historical cash flow, existing debt, patient volume, the dispensing business plan and the experience of the team. They may ask how payer access was evaluated and how inventory will be managed. Every loan is subject to approval, and nothing here is a commitment to lend.
Building a Realistic Business Case
A dispensing plan should be grounded in the practice’s own data. Owners may want to estimate:
- How many oral therapy prescriptions the practice writes
- What share it could realistically dispense given payer restrictions
- Staffing and technology costs at launch and at full volume
- Inventory needs and the time between purchase and payment
- How long it may take for the service to cover its costs
Accountants and advisors familiar with practice pharmacy operations can help test assumptions before committing capital.
How Dispensing May Affect Practice Value
A well-run dispensing operation may be viewed as part of the practice’s earnings when it is valued or sold, but buyers and appraisers will look closely at its stability, payer access and regulatory structure. Our article on oncology practice valuation explains how ancillaries are evaluated.
Phasing the Launch
Some practices start with a limited formulary or a subset of patients and expand as payer access and staffing allow. Phasing can reduce up-front inventory and staffing costs and give the team time to refine workflows before volume grows. Starting small also allows the practice to confirm its payer access assumptions with real prescriptions rather than estimates. A phased launch can also give lenders a clearer track record if the practice later seeks additional financing for growth.
Final Thoughts
Oncology in-office dispensing can bring oral therapy management closer to patients and the care team, but it requires careful planning around licensing, payer access, staffing, technology and inventory. With a realistic business case and financing that matches build-out and inventory needs, a practice can evaluate whether a pharmacy fits its long-term strategy.
US Medical Funding helps oncology practices finance new service lines and practice growth. Learn more about our oncology practice expansion financing.
